<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556555</url>
  </required_header>
  <id_info>
    <org_study_id>552/03</org_study_id>
    <nct_id>NCT01556555</nct_id>
  </id_info>
  <brief_title>Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)</brief_title>
  <official_title>Prospective Evaluation of the Clinical Utility of Peroral Cholangiopancreatoscopy With the Spyglass System in Patients With Sclerosing Cholangitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to prospectively evaluate the clinical utility of Spyglass in sclerosing
      cholangitis patients undergoing endoscopic retrograde cholangiopancreaticography (ERCP).
      Fifty patients with a definite diagnosis of sclerosing cholangitis and a clinical indication
      for ERCP from September 2008 and onwards will be investigated with peroral cholangioscopy
      using Spyglass direct visualization system. Clinical data on all patients will be collected
      at time of the ERCP including information on the Primary sclerosing cholangitis (PSC) and
      inflammatory bowel disease (IBD), serum liver function tests and indication for ERCP.

      A structured data collection form including information on Majoie Score, macroscopic features
      of the bile ducts at cholangioscopy, quality of the investigation, technical difficulties,
      and an overall judgment of whether any abnormalities observed were benign or malignant was
      completed by the endoscopist in conjunction with the procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Sclerosing Cholangitis</condition>
  <arm_group>
    <arm_group_label>Primary sclerosing cholangitis</arm_group_label>
    <description>Patients with a definite diagnosis of sclerosing cholangitis and a clinical indication for ERCP.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with SC, sclerosing cholangitis, who is undergoing ERCP, (Endoscopic Retrograde
        Cholangio and Pancreaticography)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sclerosing cholangitis with indication for ERCP

          -  Over 18 year

          -  informed consent

        Exclusion Criteria:

          -  Not able to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annika Bergquist, Assoc prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska University Hospital, Huddinge</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2012</study_first_submitted>
  <study_first_submitted_qc>March 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <last_update_submitted>March 15, 2012</last_update_submitted>
  <last_update_submitted_qc>March 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Annika Bergquist</investigator_full_name>
    <investigator_title>Head of department of gastroenterology and hepatology, associate professor</investigator_title>
  </responsible_party>
  <keyword>Sclerosing cholangitis</keyword>
  <keyword>Spyglass</keyword>
  <keyword>Endoscopic retrograde cholangiopancreaticography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Cholangitis, Sclerosing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

